Plantarc Bio Ltd (PLNT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Plantarc Bio Ltd (PLNT) has a cash flow conversion efficiency ratio of -0.235x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.79 Million ≈ $-4.79K USD) by net assets (ILA7.61 Million ≈ $20.41K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Plantarc Bio Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Plantarc Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Plantarc Bio Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Plantarc Bio Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Plantarc Bio Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MEP Infrastructure Developers Limited
NSE:MEP
|
-0.376x |
|
Medigene AG
XETRA:MDG1
|
-0.180x |
|
CAP-EX IRON ORE
F:X0V
|
-0.025x |
|
Brown Advisory US Smaller Companies PLC
LSE:BASC
|
-0.002x |
|
Verney-Carron S.A
PA:MLVER
|
N/A |
|
ActiveOps PLC
LSE:AOM
|
-0.136x |
|
Smiths News PLC
LSE:SNWS
|
2.916x |
|
Totalindo Eka Persada Tbk PT
JK:TOPS
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Plantarc Bio Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of Plantarc Bio Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see Plantarc Bio Ltd (PLNT) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA9.53 Million ≈ $25.54K |
ILA-1.47 Million ≈ $-3.95K |
-0.155x | +43.25% |
| 2023-12-31 | ILA11.96 Million ≈ $32.06K |
ILA-3.26 Million ≈ $-8.73K |
-0.272x | -10.60% |
| 2022-12-31 | ILA13.60 Million ≈ $36.46K |
ILA-3.35 Million ≈ $-8.98K |
-0.246x | -7.68% |
| 2021-12-31 | ILA17.72 Million ≈ $47.50K |
ILA-4.05 Million ≈ $-10.87K |
-0.229x | +84.32% |
| 2020-12-31 | ILA1.19 Million ≈ $3.20K |
ILA-1.74 Million ≈ $-4.66K |
-1.459x | -129.83% |
| 2019-12-31 | ILA3.29 Million ≈ $8.82K |
ILA-2.09 Million ≈ $-5.60K |
-0.635x | +39.03% |
| 2018-12-31 | ILA1.70 Million ≈ $4.57K |
ILA-1.77 Million ≈ $-4.75K |
-1.041x | -- |
About Plantarc Bio Ltd
PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.